Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Publication year range
1.
Diabetes Technol Ther ; 12(1): 89-94, 2010 Jan.
Article in English | MEDLINE | ID: mdl-20082590

ABSTRACT

PURPOSE: This study investigated reasons for the rejection and discontinuation of insulin pump therapy and explored general attitudes towards this mode of therapy among young patients with type 1 diabetes. METHODS: A questionnaire was developed using a focus group of young people with diabetes. It was then used to survey a random sample of adolescents and young people identified by physicians specializing in diabetes care and participating in a voluntary quality improvement initiative in Germany. The physicians were also surveyed. RESULTS: Eighty-eight patients participated in the survey (22 had never used the pump, 20 had formerly used the pump, and 46 were using the pump at that time, with an average age of between 20 and 22 years, depending on the group). Those who had never used the pump had had diabetes for a significantly shorter length of time and had undergone their first diabetes education more recently. Current pump users were significantly younger at the time of the first diabetes education. There were no significant differences between patients concerning where they obtained their information about the condition and treatment options. Although clinical factors were named, social and psychological factors were prominent as reasons both in reluctance to try the pump therapy and in discontinuing therapy. Technical problems as a disadvantage of the pump (aside from the catheter) were less likely to be named. Responses among physicians confirmed discipline and compliance were essential prerequisites for this therapy and supported findings that patients discontinuing pump therapy at their own request tend to do so for nonclinical reasons. CONCLUSIONS: Although the technical reliability of the insulin pump was generally accepted by all patients regardless of current treatment, clinical disadvantages relating to the use of the pump but more commonly social/psychological factors were named, which resulted in patients being reluctant to try this therapy or discontinuing use of it.


Subject(s)
Attitude , Diabetes Mellitus, Type 1/drug therapy , Diabetes Mellitus, Type 1/psychology , Insulin Infusion Systems/psychology , Patient Satisfaction , Adolescent , Age Factors , Aging/psychology , Child , Female , Germany , Humans , Injections/methods , Injections/psychology , Insulin/administration & dosage , Insulin/therapeutic use , Male , Patient Education as Topic , Patient Selection , Surveys and Questionnaires , Treatment Refusal/psychology , Young Adult
2.
Wien Med Wochenschr ; 159(5-6): 126-33, 2009.
Article in German | MEDLINE | ID: mdl-19343289

ABSTRACT

OBJECTIVE: To determine the prevalence of late complications in a large clinical sample of type 2 diabetic patients in Austria. METHODS: Data of all patients with type 2 diabetes entered into the database of the Forum for Quality Systems in Diabetes Care Austria (FQSD-A) between 1 January 1997 and 1 September 2007 were used for the analyses. RESULTS: Data from 23,641 persons with Type 2 Diabetes Mellitus were collected. Patients were 66.3 +/- 11.5 years old, with an average diabetes duration of 8.0 +/- 8.5 years. Prevalence of blindness, amputation, myocardial infarction or bypass, stroke and end stage renal failure was 0.9%, 2.3%, 12.2%, 8.7% and 0.8%, respectively. CONCLUSIONS: Prevalence of late diabetic complications in Austria is high compared with other European countries. The management of persons with Type 2 Diabetes should be further optimized to reduce the incidence of late complications of diabetes.


Subject(s)
Diabetes Complications/epidemiology , Diabetes Mellitus, Type 2/complications , Diabetes Mellitus, Type 2/epidemiology , Health Status , Quality Assurance, Health Care , Aged , Austria , Benchmarking , Cross-Cultural Comparison , Databases, Factual , Diabetes Complications/therapy , Diabetes Mellitus, Type 2/therapy , Education , Europe , Female , Humans , Male , Management Quality Circles , Middle Aged
3.
SELECTION OF CITATIONS
SEARCH DETAIL
...